Here are four things to know about Mr. Brynjelsen.
1. In his new role, he will develop and execute a strategy for long-term growth through the acceleration of product licensing, acquisition of products and portfolios as well as the execution of other merger and acquisition activity, Sagent said.
2. Mr. Brynjelsen has more than two decades of transactional experience in the pharmaceutical industry with companies including Akorn, Hospira and Baxter.
3. Most recently, he was senior vice president of global business development for Akorn.
4. Mr. Brynjelsen earned a master’s degree in business administration from the University of Notre Dame (Ind.), and earned a master’s degree in chemistry and a bachelor’s degree in BioChemistry from the University of Illinois, based in Urbana.
More articles on executive moves:
Tenet executive picked to lead Providence Health & Services, Southern California: 4 things to know
Jerry Hadley named VP of finance for Brigham and Women’s Faulkner: 3 things to know
SmartLinx appoints new executives: 6 things to know
